Chemours Company (the) · NYSE:CC

Chemours Company (the) — Q4 2025 Earnings Presentation

29 slides from Chemours Company (the)'s earnings presentation, Feb 20, 2026

  1. Slide 1: The Chemours Company Q4 & Full Year 2025 Earnings Presentation

    THE CHEMOURS COMPANY Q4 & FULL YEAR 2025 EARNINGS PRESENTATION February 20, 2026

  2. Slide 2: Safe Harbor Statement and Other Matters

    Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current exp

  3. Slide 3: Fourth Quarter & Full Year 2025 Highlights

    Fourth Quarter & Full Year 2025 Highlights Generated $1.3B in Net Sales and $128M in Adjusted EBITDA in 4Q25, driving Net Sales of $5.8B and Adjusted EBITDA of $742M for the year Achieved 37% 4Q25 and 56% full year 2025 YoY Net Sales growth for Opteon Refrigerants in TSS, reflecting continued strong

  4. Slide 4: Full Year 2025 Financial Summary

    Full Year 2025 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) FY25 FY24 5 Y-o-Y ∆ Net Sales $5,808 $5,782 $26 Net (Loss) / Income 1 ($386) $69 ($455) Adj. Net Income 2 $143 $179 ($36) EPS 3 ($2.57) $0.46 ($3.03) Adj. EPS 2,3 $0.95 $1.19 ($0.24) Adj. EBITDA 2,4 $

  5. Slide 5: Fourth Quarter 2025 Financial Summary

    Fourth Quarter 2025 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 4Q25 4Q24 5 Y-o-Y ∆ 3Q255 Q-o-Q ∆ Net Sales $1,329 $1,359 ($30) $1,495 ($166) Net (Loss) / Income1 ($47) ($11) ($36) $46 ($93) Adj. Net Income 2 $7 $14 ($7) $26 ($19) EPS 3 ($0.31) ($0.08) ($0.39

  6. Slide 6: Adjusted EBITDA Bridge: FY25 versus FY24

    Adjusted EBITDA Bridge: FY25 versus FY24 ($ in millions) ($18) $67 ($96) $22 $768 $742 5 FY24 Price Volume Cost/Other Currency FY25 Price Impacts: ($18) million driven by lower TiO2 pigment (TT) pricing globally partially offset by higher pricing in TSS primarily driven by stronger Opteon Refrigeran

  7. Slide 7: Adjusted EBITDA Bridge: 4Q25 versus 4Q24

    Adjusted EBITDA Bridge: 4Q25 versus 4Q24 ($ in millions) $13 ($10) ($56) $13 $168 $128 4Q24 5 Price Volume Cost/Other Currency 4Q25 Price Impacts: $13 million due to higher pricing in TSS primarily driven by stronger Opteon Refrigerant blends mix paired with higher pricing associated with opportunis

  8. Slide 8: Full Year Segment Summary

    Full Year Segment Summary ($ in millions unless otherwise noted) Net Sales TSS TT APM $1,851 $1,831 $2,066 $2,680 $2,572 $2,429 $1,462 $1,326 $1,263 FY23 FY24 FY25 FY23 FY24 FY25 FY23 FY24 FY25 Adjusted EBITDA and Margin 5 (%) TSS TT APM $683 $571 $670 $290 $301 $145 $273 $160 $108 FY23 FY24 FY25 FY

  9. Slide 9: Quarterly Segment Summary

    Quarterly Segment Summary ($ in millions unless otherwise noted) Net Sales TSS TT APM $380 $390 $444 $651 $632 $561 $326 $324 $312 4Q23 4Q24 4Q25 4Q23 4Q24 4Q25 4Q23 4Q24 4Q25 Adjusted EBITDA and Margin 5 (%) TSS TT APM $122 $122 $128 $64 $70 $23 $12 $40 $47 4Q23 4Q24 4Q25 4Q23 4Q24 4Q25 4Q23 4Q24 4

  10. Slide 10: Liquidity Position as of December 31, 2025

    Liquidity Position as of December 31, 2025 ($ in millions unless otherwise noted) Total Liquidity 10 $1.6B Gross Debt $4.2B Net Debt 11 $3.5B TTM Net Leverage 12 4.7x $724 $665 ($45) ($15) ($18) $54 Restricted $52 Restricted $137 $670 $613 Unrestricted Unrestricted 7 8 9 7 3Q25 Cash Balance Operatin

  11. Slide 11: Strategic Progress

    STRATEGIC PROGRESS PATHWAY TO THRIVE

  12. Slide 12: Our Strategy

    Our Strategy PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long-Term ❑Manufacturing excellence as a basis for success ❑Investing smartly in selected ❑Holistic portfolio analysis ❑Measurable progress on growth projects focused on distinct value resolv

  13. Slide 13: Progress Achieved to Date

    Progress Achieved to Date PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long-Term ✓ Delivered a minimum of $125 ✓ Continued double-digit growth with ✓ Progressed APM European asset ✓ Agreed to a proposed Judicial million of cost savings within 37% Yo

  14. Slide 14: Q1 and Full Year Guidance

    Q1 AND FULL YEAR GUIDANCE

  15. Slide 15: First Quarter and Full Year 2026 Guidance

    First Quarter and Full Year 2026 Guidance Sequential Business Outlook: First Quarter 2026 Outlook Full Year 2026 Outlook  Consolidated o Net Sales: Expected to increase in the 3 to 5% range sequentially o Adjusted EBITDA: Expected to range between $120 million and $150 million o Corporate Expenses:

  16. Slide 16: Appendix

    APPENDIX 16

  17. Slide 17: TSS Segment Net Sales and Adjusted EBITDA (Unaudited)

    TSS Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) % of total Net Sales $444 $390 $10 FP&O 20% FP&O $44 23% FreonTM Refrigerants FreonTM 25% Refrigerants 4Q25 % total 32% 4Q24 % total refrigerants: refrigerants: Freon = 32% OpteonTM OpteonTM Freon = 41% Opteon = 6

  18. Slide 18: TT Segment Net Sales and Adjusted EBITDA (Unaudited)

    TT Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) $632 Minerals 5% $561 $(28) Minerals 5% $(43) TiO2 95% TiO2 95% $70 $23 4Q24 Price/Currency Volume 4Q25 4Q24 Price/Currency Volume Cost/Other 4Q25 Net Sales: The decrease was driven by year-over-year lower TiO2 pig

  19. Slide 19: APM Segment Net Sales and Adjusted EBITDA (Unaudited)

    APM Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) % of total Net Sales $324 $312 $15 Performance ($27) Solutions Performance 41% Solutions 45% • Non-cash inventory Advanced charges Advanced • Lower utilization Materials Materials levels 59% 55% $47 • Idling costs

  20. Slide 20: Segment Net Sales (Unaudited)

    Segment Net Sales (Unaudited)5 2023 2024 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Net sales by product group and segment TM Opteon refrigerants $ 195 $ 200 $ 170 $ 145 $ 200 $ 227 $ 205 $ 178 $ 279 $ 375 $ 368 $ 243 TM Freon refrigerants 185 226 170 141 173 173 146 124 97 123 98 113 Foam, propellant

  21. Slide 21: Segment Net Sales by Region (Unaudited)

    Segment Net Sales by Region (Unaudited)5 2023 2024 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Net sales by geographic region North America: Thermal & Specialized Solutions $ 292 $ 319 $ 258 $ 207 $ 271 $ 308 $ 256 $ 194 $ 233 $ 336 $ 316 $ 241 Titanium Technologies 262 277 273 242 246 274 270 236 267

  22. Slide 22: Disruption & Investment Costs (Unaudited)

    Disruption & Investment Costs (Unaudited) 2024 2025 ($, millions) Q1 Q2 Q3 Q4 Total Q1 Q2 Q3 Q4 Total Disruption Costs Thermal & Specialized Solutions (TSS) Winter Storm $ - $ - $ - $ - $ - $ 5 $ - $ - $ - $ 5 Titanium Technologies (TT) Impacts from Altamira Outage - 8 18 - 26 - - - - - Winter Storm

  23. Slide 23: Segment Net Sales and Adjusted EBITDA (Unaudited)

    Segment Net Sales and Adjusted EBITDA (Unaudited)5 2023 2024 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Segment Net Sales Thermal & Specialized Solutions $ 494 $ 533 $ 444 $ 380 $ 454 $ 519 $ 468 $ 390 $ 466 $ 597 $ 560 $ 444 Titanium Technologies 632 707 690 651 592 676 672 632 597 657 612 561 Advanc

  24. Slide 24: GAAP Net Income (Loss) to Adjusted Net Income and Adjusted EBITDA (Page 1/2)

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio5 (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Year Ended December 31, September 30

  25. Slide 25: GAAP Net Income (Loss) to Adjusted Net Income and Adjusted EBITDA (Page 2/2)

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio5 (Page 2/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Year Ended December 31, September 30

  26. Slide 26: GAAP Operating Cash Flow to Free Cash Flow and FCF Conversion Reconciliation

    GAAP Cash Flow Provided by Operating Activities to Free Cash Flows and Free Cash Flow Conversion Reconciliation 1 1. For the year ended December 31, 2024, operating cash outflows includes the release of the $606 million of cash and cash equivalents deposited in the qualified settlement fund per the

  27. Slide 27: 2026 Estimated GAAP Net Income to Estimated Adjusted NI and EBITDA Reconciliation

    2026 Estimated GAAP Net Income Attributable to Chemours to Estimated Adjusted NI, Estimated Adj. EBITDA & 2026 Estimated GAAP Cash Flow Provided by Operating Activities to Free Cash Flows and FCF Conversion Reconciliation (Estimated) Year Ending December 31, 2026 Low High Net income attributable to

  28. Slide 28: Revisions to Previously Presented Segment Net Sales and Adjusted EBITDA

    Revisions to Previously Presented Segment Net Sales, Segment Adjusted EBITDA, Adjusted Net Income and Consolidated Adjusted EBITDA5 Year Ended December 31, 2023 Year Ended December 31, 2024 As Reported Revision As Revised As Reported Revision As Revised Segment Adjusted EBITDA Thermal & Specialized

  29. Slide 29: ® 2026 CHEMOURS. ALL RIGHTS RESERVED​

    ® 2026 CHEMOURS. ALL RIGHTS RESERVED​

Chemours Company (The) — Q4 2025 Earnings Presentation on 6ix